Additionally, CD8+Tcm cells were higher in the Recombinant COVID-19 Vaccine (Sf9 Cells) group (7.362 ± 4.467) compared to the CONVIDECIA group (P<0.1). This evidence concerns the gene CD8A and COVID-19.